Active substance
Ectoine
- SFDA 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Artelac Ectoin SDU | 20 mg | Eye drops · Ocular use | 20 Ampoule | SAR 36.85 | Generic · OTC | Dr. Gerhard Mann Chem. - Pharma. Fabrik GmbH | Valid |
| BETADINE SOOTHING RELIEF DRY & TIRED EYES | 0.5 % | Eye drops · Ophthalmic use | 10 Bottle | SAR 18.60 | Health · OTC | MUNDIPHARMA MEDICAL COMPANY | Withdrawn by MAH · Not Marketed |
| BETADINE SOOTHING RELIEF EAR CANAL RELIEF | 2 % | Spray · Auricular use | 1 Bottle | SAR 17.00 | Generic · OTC | MUNDIPHARMA MEDICAL COMPANY | Withdrawn by MAH · Not Marketed |
| BETADINE SOOTHING RELIEF EYE ALLERGY AMPOULE | 2 % | Eye drops · Ophthalmic use | 10 Bottle | SAR 18.60 | Health · OTC | MUNDIPHARMA MEDICAL COMPANY | Withdrawn by MAH · Not Marketed |
| BETADINE SOOTHING RELIEF EYE ALLERGY BOTTLE | 2 % | Eye drops · Ophthalmic use | 1 Bottle | SAR 37.20 | Health · OTC | MUNDIPHARMA MEDICAL COMPANY | Withdrawn by MAH · Not Marketed |
| ECTOLLERG 1% EYE DROPS | 1 % | Eye drops · Ophthalmic use | 20 Ampoule | SAR 37.20 | Generic · OTC | Bitop AG | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC CONJUCTIVITIS (AC); BELL'S PALSY; SJOGREN'S SYNDROME; VIRAL CONJUNCTIVITS, HERPESVIRAL KERATITIS, HERPESVIRAL CONJUNCTIVITIS, VARICELLA KERATITIS, ZOSTER CONJUNCTIVITIS, ZOSTER KERATITIS, MEASLES KERATITIS AND KERATOCONJUNCTIVITIS, VIRAL CONJUNCTIVITIS, KERATITIS
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.